Growth Hormone and IGF-1 Actions in the Brain and Neuropsychiatric Diseases.

Aguiar-Oliveira, Manuel H et al.·Physiology (Bethesda·2026·
RPEP-147022026RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Not classified
Evidence
Not graded
Sample
Not reported

What This Study Found

Key Numbers

How They Did This

Why This Research Matters

What This Study Doesn't Tell Us

Trust & Context

Original Title:
Growth Hormone and IGF-1 Actions in the Brain and Neuropsychiatric Diseases.
Published In:
Physiology (Bethesda, Md.), 41(1), 0 (2026)
Database ID:
RPEP-14702

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study
What do these levels mean? →

Read More on RethinkPeptides

Related articles coming soon.

Cite This Study

RPEP-14702·https://rethinkpeptides.com/research/RPEP-14702

APA

Aguiar-Oliveira, Manuel H; Boguszewski, Margaret C S; Rovaris, Diego L; Donato, Jose. (2026). Growth Hormone and IGF-1 Actions in the Brain and Neuropsychiatric Diseases.. Physiology (Bethesda, Md.), 41(1), 0. https://doi.org/10.1152/physiol.00009.2025

MLA

Aguiar-Oliveira, Manuel H, et al. "Growth Hormone and IGF-1 Actions in the Brain and Neuropsychiatric Diseases.." Physiology (Bethesda, 2026. https://doi.org/10.1152/physiol.00009.2025

RethinkPeptides

RethinkPeptides Research Database. "Growth Hormone and IGF-1 Actions in the Brain and Neuropsych..." RPEP-14702. Retrieved from https://rethinkpeptides.com/research/aguiar-oliveira-2026-growth-hormone-and-igf1

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.